Risk Attribute Analysis and Risk of Adherence to Taking Medication for Pulmonary TB Patients at the Jayapura Regency Office

Hasmi Hasmi; Sarce  Makaba

doi:10.55927/fjst.v3i11.12286

Authors

Hasmi Hasmi Master of Public Health Sciences Program, Cenderawasih University
Sarce Makaba Master of Public Health Sciences Program, Cenderawasih University

DOI:

https://doi.org/10.55927/fjst.v3i11.12286

Keywords:

Compliance, Taking Medicine, Pulmonary TB

Abstract

This study aims to analyze the Risk Attributes and risks of medication adherence in patients with pulmonary TB. Type of survey research designed by cross sectional. A sample of 81 people was taken using the purposive sampling technique. The results of the study were with the variable value of RA = -21%, RP=1(0.19-5.9), gender RA=18%, PR 1.7(0.9-3.3), education RA=-16%, PR =0.57. Work RA = 19%, RP = 2.12 (0.72-6.22). TB MDR RA =62%, RP=16 (5.2-48.4). Side effects of RA Drug = 30%, PR = 2.5 (1.2-4.88), History of Comorbidities RA = 61%, PR = 3.6(2.02-6.6), duration of treatment RA = 50% PR = 3.8 (2-7). The variable that contributes the most to medication adherence is MDR TB status.

Downloads

Download data is not yet available.

References

Anisah, A., Sumekar, D. W., & Budiarti, E. (2021). Hubungan Demografi dan Komorbid dengan Kejadian Tuberkulosis Resisten Obat (TB RO). Jurnal Ilmiah Kesehatan Sandi Husada, 10(2), 568–574. https://doi.org/10.35816/jiskh.v10i2.655

Bawonte, T. G., Mambo, C. D., & Masengi, A. S. R. (2021). Faktor-Faktor Yang Mempengaruhi Tuberculosis Multidrug Resistance (TB MDR). Jurnal E-Biomedik, 9(1), 117–125. https://doi.org/10.35790/ebm.v9i1.31949

Gulo, A., Warouw, S. P., & Brahmana, N. E. B. (2021). Analisis faktor risiko kejadian penyakit tuberkulosis paru di wilayah kerja UPT Puskesmas Padang Bulan Kota Medan tahun 2020. Journal of Healthcare Technology and Medicine, 7(1), 128–137.

Indriani, L., Renitia, G. I., & Setiani, L. A. (2023). Treatment Duration and Drug Regimen Correlation with Side Effects Incidence in Drug-Resistant Tuberculosis (DR-TB) Patients at Pulmonary Hospital. Jurnal Sains Farmasi & Klinis, 10(3), 320. https://doi.org/10.25077/jsfk.10.3.320-326.2023

Kemenkes, R. (2022). Profil Kesehatan Indonesia. Kemenkes RI.

Kementerian Kesehatan, B. (2023). SKI 2023.

Kesehatan, D. (2023). Profil Kesehatan Provinsi Papua. Dinkes Provinsi Papua.

Lestari, B. W., Nijman, G., Larasmanah, A., Soeroto, A. Y., Santoso, P., Alisjahbana, B., Chaidir, L., Andriyoko, B., van Crevel, R., & Hill, P. C. (2024). Management of drug-resistant tuberculosis in Indonesia: a four-year cascade of care analysis. The Lancet Regional Health - Southeast Asia, 22. https://doi.org/10.1016/j.lansea.2023.100294

Meliana Depo. (2022). DETERMINANTS OF ADHERENCE TO TUBERCULOSIS TREATMENT IN SORONG CITY Dirgantari Pademme.

Notoatmodjo, S. (2014). Ilmu Kesehatan Masyarakat, Perilaku dan Seni. Rineka Cipta.

Putri Nurjannah Kurita. (2024, March). Penderita TBC di Kabupaten Jayapura 168 Orang hingga Akhir Maret 2024. Tribun.

Saputra, H. L., Yulendasari, R., & Kusumaningsih, D. (2022). Faktor-faktor yang berhubungan dengan Multidrug Resistant Tuberculosis (MDR-TB) pada pasien tuberkulosis paru. Holistik Jurnal Kesehatan, 16(6), 516–528. https://doi.org/10.33024/hjk.v16i5.8161

Sukarno, A., Dewi, R., Mulyana, B., Arjuna Utara No, J., Kebon Jeruk, K., & Jakarta, D. (2023). Hubungan Efek Samping Obat Anti Tuberkulosis (OAT) terhadap Kepatuhan Pengobatan Pasien TB Paru di Puskesmas Baja Kota Tangerang. Indonesian Journal of Nursing Health Science ISSN, 8(2), 123–131.

Wahyuni, T. (2020). Faktor-faktor yang berhubungan dengan kejadian multidrug resistant tuberkulosis (mdr-tb). 96.

WHO. (2024, May 20). Tuberculosis: Multidrug-resistant (MDR-TB) or rifampicin-resistant TB (RR-TB). WHO.